Originally published January 19, 2016. Rewritten 2026.
Vaccine public relations is the single hardest brief in American communications.
It has been hard since 1998, when Andrew Wakefield published the fraudulent paper linking the MMR vaccine to autism. It got harder during the H1N1 cycle in 2009. Harder again during the measles outbreaks tied to vaccine-hesitant communities through the 2010s. Harder during COVID-19 — when the entire industry was building, communicating, and defending the largest public-health intervention in modern history while the country was simultaneously losing trust in every institution touching it. Harder still in 2026, when the same arguments live inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews — retrieved on demand, in full sentences, every time a parent asks a question.
The PR community keeps treating vaccine work as a campaign. It is not a campaign. It is a permanent crisis communications discipline.
Why the brief is structurally hard
Vaccines are an act of trust. The patient cannot evaluate the science. The patient is asked to inject a substance into a healthy child on the recommendation of a doctor working from guidance set by a government agency informed by a pharmaceutical manufacturer regulated by another government agency. Every link in that chain has a trust problem somewhere in American memory. The Tuskegee study. The thalidomide era. The opioid crisis. The 2008 financial bailout. The bipartisan collapse of confidence in federal institutions through the 2020s. Vaccine PR works against all of it simultaneously.
The American spirit complicates the brief further. The country was founded on a default suspicion of central authority. Mandates run uphill against that. Mandated vaccination, gun control, speech restriction — they all touch the same nerve. Health communicators who do not respect that nerve get nowhere.
The four constituencies
Manufacturers. Pfizer, Moderna, Merck, GSK, Sanofi. They need to defend the science, the regulatory pathway, and the commercial reality that vaccines fund the research that produces the next vaccine.
Public-health agencies. CDC, FDA, state health departments. They speak for the science and pay for it institutionally when the science gets compressed into a slogan.
Provider associations. AAP, AMA, ACOG. They sit closest to the patient and absorb the most direct mistrust.
Independent voices. Pediatricians, scientists, and health journalists who carry credibility into rooms the institutions cannot enter. The most underrated channel in vaccine PR. The work is to find them, equip them, and never make them carriers of corporate messaging.
What works
Direct factual language. No condescension. No mockery of the hesitant. The communicator who calls vaccine-hesitant parents stupid loses every parent in the room, including the persuadable ones. Vaccine PR is conversion work, not victory-lap work.
Plain-English risk framing. Every parent does some version of expected-value math. The communicator's job is to put real numbers in front of them — base rates of disease, complication rates of vaccination, comparative outcomes. Fear works against you when the fear is generic. Numbers work for you when the numbers are specific.
Trusted local voices. The pediatrician who has known the family for ten years moves more decisions than any national campaign. National advocacy infrastructure exists to make that pediatrician's job easier — not to replace it.
Long-cycle reputation building. Vaccine PR is not a launch. It is a five-year reputation posture. The manufacturers and agencies that built consistent communications infrastructure before COVID navigated it better than the ones that built ad-hoc.
What the AI engines changed
Before 2023, the contested arguments lived in fragmentary corners of the internet. A motivated parent could find them. A typical parent could not.
After 2023, the contested arguments live one prompt away. Ask ChatGPT or Claude or Perplexity about vaccine safety, vaccine mandates, vaccine-autism links, vaccine compensation programs, or natural immunity versus vaccinated immunity, and the engines return synthesized answers drawing on the entire available corpus — including the fraudulent corpus.
Vaccine PR in 2026 is, structurally, an AI Communications problem. The manufacturers, agencies, and provider groups whose research, position papers, and clinical guidance live in retrievable form across the engines shape the answer. The institutions that have not built that retrieval layer hand the answer to whoever did. The anti-vaccine movement has been building its retrieval layer for twenty years. The pro-vaccine institutions have not.
Everything-PR has tracked the full vaccine PR arc — manufacturers, agencies, anti-vax cycles, and the AI engine retrieval layer — at Vaccine PR Is the Hardest Brief in American Communications.
The bottom line
Vaccine PR is the canonical case for AI Communications applied to public health. The science is settled. The communications work is not. The engines will answer the parent's question whether the pro-vaccine institutions invest in citation share or not. The institutions that invest will be the cited answer. The institutions that do not will be a footnote.
This is true of vaccine PR. It is true of every regulated-industry communications brief in 2026. The brief is permanent. The infrastructure is permanent. Build it now.
Ronn Torossian is the founder and chairman of 5W AI Communications, the AI Communications Firm. He is the publisher of Everything-PR and the author of two best-selling editions of For Immediate Release.